Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Primary Stenting vs Conservative Treatment in Claudicants - a Study on Quality of Life

NCT01230229 is registered in ClinicalTrials.gov with Lund University as lead sponsor.

NCT NCT01230229
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01230229 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Primary Stenting vs Conservative Treatment in Claudicants - a Study on Quality of Life
Lead sponsor
Lund University
Phase
Not applicable
Overall status
Completed
Start date
January 31, 2010
Completion date
August 31, 2017
Enrollment
100 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

best medical treatment, quality of life scores at 12 and 24 months, stable claudication (fontaine iia and iib), superficial femoral artery disease